Jorg Moller

Title: Jorg Moller - Innovator in Biochemical Processes

Introduction

Jorg Moller is a distinguished inventor based in Soden, Germany. He has made significant contributions to the field of biochemistry, particularly in processes that enhance the efficacy of therapeutic proteins. With one patent to his name, Moller showcases a commitment to advancing innovation in medical applications.

Latest Patents

Moller's notable patent is titled "Process for inactivating carboxypeptidase Y in hirudin-containing culture broth." This invention relates to a method for inactivating Carboxypeptidase Y (CPY) produced by fermenting a transformed yeast, which can be crucial for improving the stability of hirudin, a key anticoagulant. The patented process effectively heats a broth containing both hirudin and CPY to a temperature of approximately 80°C to 100°C within one minute or less, thus preventing the degradation of hirudin caused by active peptidases.

Career Highlights

Jorg Moller has been associated with Hoechst Aktiengesellschaft, where he utilizes his expertise in biochemistry to drive innovations in therapeutic products. His work exemplifies the intersection of scientific research and practical applications in healthcare.

Collaborations

Throughout his career, Moller has collaborated with talented individuals, including colleagues Peter Crause and Paul Habermann. These partnerships have enhanced the research and development efforts within his field, contributing to the success of their innovative projects.

Conclusion

In conclusion, Jorg Moller represents a forward-thinking inventor whose work in inactivating Carboxypeptidase Y has the potential to impact the biopharmaceutical sector significantly. His dedication to innovation continues to pave the way for advancements in the safe use of therapeutic proteins, benefiting both healthcare providers and patients alike.